Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;21(12):2552-2562.
doi: 10.1016/j.hrthm.2024.09.053. Epub 2024 Sep 27.

Implantation techniques for a helix-fixation dual-chamber leadless pacemaker

Petr Neuzil  1 , Chris Hubbard  2 , Rahul N Doshi  3 , Vivek Y Reddy  4 , Robert Canby  5 , Pascal Defaye  6 , Derek V Exner  7 , Morio Shoda  8 , Maria Grazia Bongiorni  9 , Gerhard Hindricks  10 , Thomas Callahan  11 , Sri Sundaram  12 , Kenneth P Bruhns  2 , Daniel F Booth  2 , Reinoud E Knops  13 , James E Ip  14
Affiliations
Free article
Review

Implantation techniques for a helix-fixation dual-chamber leadless pacemaker

Petr Neuzil et al. Heart Rhythm. 2024 Dec.
Free article

Abstract

In a pivotal trial (NCT05252702), the AVEIR DR (Abbott) leadless pacemaker system was found to be safe and effective in delivering DDDR synchronous atrial and ventricular pacing. This dual-chamber system employs 2 leadless pacemakers with implant-to-implant communication. Although implantation of the ventricular device as a single-chamber pacemaker has been well described, there are additional considerations surrounding the dual-chamber implantation procedure. Herein, we review the dual-chamber leadless pacemaker implantation workflow while providing guidance to optimize safe and effective implantation procedures.

Keywords: AV synchrony; AVEIR DR; Dual-chamber leadless pacemaker; Implant technique; i2i communication.

PubMed Disclaimer

Conflict of interest statement

Disclosures P.N., R.N.D., V.Y.R., D.V.E., T.C., S.S., R.E.K., and J.E.I. report Abbott consulting fees. P.D., D.V.E., and R.E.K. report Abbott research grants. D.V.E., T.C., and S.S. report Abbott honoraria. R.N.D., M.S., M.G.B., G.H., R.E.K., and J.E.I. serve as Abbott steering committee members. Unrelated to this manuscript: V.Y.R. serves as a consultant for and has equity in Ablacon, Acutus Medical, Affera-Medtronic, Anumana, Apama Medical–Boston Scientific, APN Health, Aquaheart, Atacor, Autonomix, Axon Therapies, Backbeat, BioSig, CardiaCare, Cardiofocus, CardioNXT/AFTx, Circa Scientific, CoRISMA, Corvia Medical, Dinova-Hangzhou DiNovA EP Technology, East End Medical, EP Frontiers, Farapulse, Field Medical, Focused Therapeutics, HRT, Intershunt, Javelin, Kardium, Keystone Heart, Laminar Medical, LuxMed, Medlumics, Neutrace, Nuvera–Biosense Webster, Oracle Health, Pulse Biosciences, Restore Medical, Sirona Medical, SoundCath, Valcare; unrelated to this work, he has served as a consultant for Adagio Medical, Append Medical, AtriAN, BioTel Heart, Biosense Webster, Biotronik, Boston Scientific, Cairdac, Cardionomic, CoreMap, Fire1, Gore & Associates, Impulse Dynamics, Medtronic, Novartis, Novo Nordisk, and Philips; and unrelated to this work, he has equity in Atraverse, DRS Vascular, Manual Surgical Sciences, Newpace, Nyra Medical, Soundcath, Surecor, and Vizaramed. R.C. reports consulting fees from Medtronic. T.C. reports speaking and consulting fees from Medtronic, Philips, Boston Scientific, and ShockWave. S.S. holds an unrelated patent with Abbott. R.E.K reports research grants and consulting fees from and serves as a steering committee member of Boston Scientific and reports speaking fees from Medtronic. J.E.I. reports consulting fees from Medtronic and serves as a Data Safety Monitoring Committee member of Boston Scientific.

MeSH terms

LinkOut - more resources